Cabaletta Bio

CABA · NASDAQ

$1.61+$0.13 (+8.78%)TodayMarket closed · Oct 20, 7:58 PM ET

Prev close $1.48

Latest news

NewsSep 1, 8:02 AM ETAvi Kapoor
Cango, Nio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Press releaseSep 1, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in Upcoming Investor Conferences
Press releaseAug 13, 7:30 AM ETGlobe Newswire
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Press releaseJun 3, 7:00 AM ETGlobe Newswire
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
Press releaseMay 14, 7:05 AM ETGlobe Newswire
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
Press releaseMay 14, 7:00 AM ETGlobe Newswire
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
NewsMay 4, 9:54 AM ETAvi Kapoor
Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday
Press releaseApr 28, 8:00 AM ETBusiness Wire
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel
Press releaseApr 28, 8:00 AM ETGlobe Newswire
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
Press releaseApr 14, 4:30 PM ETBusiness Wire
First Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform
NewsApr 10, 8:02 AM ETAvi Kapoor
FGI Industries, Nouveau Monde Graphite And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Press releaseMar 23, 7:30 AM ETGlobe Newswire
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Press releaseFeb 24, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
Press releaseFeb 5, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Press releaseJan 12, 8:00 AM ETGlobe Newswire
Cabaletta Bio Announces 2026 Strategic Priorities
Press releaseJan 12, 7:30 AM ETBusiness Wire
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
Press releaseNov 10, 7:30 AM ETGlobe Newswire
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
NewsNov 4, 2:25 PM ETVandana Singh
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
Press releaseNov 4, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
NewsOct 31, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseAug 27, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
NewsAug 11, 8:45 AM ETVandana Singh
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction
NewsJul 30, 11:07 AM ETVandana Singh
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
NewsJul 23, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsJun 30, 8:36 AM ETVandana Singh
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
NewsJun 11, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseMay 29, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
NewsMay 16, 8:08 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsMay 15, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseMar 19, 7:00 AM ETBusiness Wire
Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform
Press releaseFeb 26, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
Press releaseJan 29, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in Guggenheim's SMID Cap Biotech Conference
NewsDec 19, 9:07 AM ETAvi Kapoor
This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
Press releaseNov 26, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in December
Press releaseNov 18, 7:00 AM ETGlobe Newswire
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
Press releaseNov 14, 7:00 AM ETGlobe Newswire
Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Press releaseNov 6, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
Press releaseAug 28, 8:00 AM ETGlobe Newswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in September

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Cango, Nio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

Cabaletta Bio to Participate in Upcoming Investor Conferences

Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday

Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel

Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel

First Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform

FGI Industries, Nouveau Monde Graphite And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference

Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Cabaletta Bio Announces 2026 Strategic Priorities

IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms

Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy

Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December

12 Health Care Stocks Moving In Friday's Intraday Session

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

12 Health Care Stocks Moving In Wednesday's After-Market Session

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers

12 Health Care Stocks Moving In Wednesday's Intraday Session

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform

Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference

Cabaletta Bio to Participate in Guggenheim's SMID Cap Biotech Conference

This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

Cabaletta Bio to Participate in Upcoming Investor Conferences in December

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024

Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Cabaletta Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Cabaletta Bio to Participate in Upcoming Investor Conferences in September